Fazio, Nicola http://orcid.org/0000-0001-6869-0704
Abdel-Rahman, Omar
Article History
Accepted: 11 January 2021
First Online: 8 February 2021
Compliance with Ethical Standards
:
: Nicola Fazio has personal financial interests (Advisory board and public speaking: Novartis, Ipsen, Pfizer, Merck Serono, Advanced Accelerator Applications, MSD, Sanofi-Aventis, and Wren Laboratories Europe) and institutional financial interests (clinical trials (P.I., Steering committee): Novartis, Ipsen, Merck Serono, MSD, Pharmacyclics, Incyte, Halozyme, Roche, Astellas, Pfizer, FivePrime, and BeiGene). Omar Abdel-Rahman has no conflicts of interest